Home / About CAGS
About CAGS
Arab Genomic Studies

In recent years, health economists have made significant advances in calculating generally accepted ‘cost of illness’ estimates for many common genetic conditions.

About CAGS

Genetic disorders are chronic ailments that require lifelong treatment and many have no definitive cure. The Arab World is especially rich in many of these genetic disorders; a factor contributed to by the wide-spread norm of consanguinity in the region, selective and environmental factors favoring the persistence of certain genetic traits, and the lack of public awareness towards the early recognition and prevention of inherited disease. As a result, several disease conditions, such as hemoglobin disorders, hypertension, diabetes mellitus, and Down Syndrome have reached epidemic values in the region. These and other genetic disorders continue to impact the health system by increased rates of neonatal deaths and morbidity and mortality in children as well as in adults. They are a significant health care and psychosocial burden for the patient, the family, the healthcare system and the community as a whole. In recent years, health economists have made significant advances in calculating generally accepted ‘cost of illness’ estimates for many common genetic conditions. It is estimated that billions of US Dollars are spent annually as a consequence of the management of just a few of the most common genetic disorders in the Arab World.

Vision, Mission and Objectives

About CAGSThe pioneering vision of H.H. Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai and UAE Minister of Finance and Industry, to alleviate human suffering from genetic diseases in the Arab World crystallized in the establishment of the Centre for Arab Genomic Studies (CAGS) on 25 June, 2003. Since then, the Centre has dedicated itself to the mission of improving human health by characterizing and preventing genetic disorders in Arab countries based on the recent advances in human genetics. To fulfil this mission, the Centre is guided by a set of objectives that are as follow:

  • To raise public awareness on the importance of genetic diseases in the Arab World.
  • To identify disease-causing genes in the Arab population and develop a comprehensive open-access database of genetic diseases in the Arab World.
  • To bring together diverse expertise and resources in the Arab World to facilitate multidisciplinary research in the field of genetics and related areas.
  • To cooperate with other research and medical institutions to ensure global access to new findings and technical developments.
  • To address the ethical, legal and social issues that may arise from genetic applications.
  • To develop a center for excellence in Dubai for genetic research and clinical services targeted towards the Arab World.
  • To prevent genetic diseases by translating research achievements into well-integrated patient treatment programs.
  • To implement the strategies for a financially independent center through revenue generating approaches.
The scientific structure of the Centre for Arab Genomic Studies includes two committees:
CAGS Executive Board

The Executive Board of CAGS is composed of a number of local scientists and it represents the governing body and the legal trustee of all activities of the centre.

CAGS Council

The Arab Council of CAGS includes regional scientists and it acts as a consultative body and facilitates the exchange of information on genetic disorders occurring in Arab countries. Countries represented in the Council of CAGS currently include: Bahrain, Egypt, Jordan, Kuwait, Lebanon, Oman, Palestine, Qatar, Saudi Arabia, Sudan, and Tunisia.